BURLINGTON, Mass., April 9 /PRNewswire-FirstCall/ --
Palomar Medical Technologies Inc (Nasdaq: PMTI) announced that it has received
clearance from the FDA for skin resurfacing for its Palomar Q-YAG 59(TM) Nd:
YAG Laser System. Laser skin resurfacing is a skin rejuvenation technique in
which light energy is used to remove a superficial layer of the skin and
stimulate collagen production in the deeper layers of the skin for an
improvement in the overall appearance of the skin. The Palomar Q-YAG 5 System
includes a dual, blendable wavelength beam of 1064nm and 532nm. As the beam
from the Palomar Q-YAG 5 System interacts with sun-damaged skin, it gently
removes the outer layer of the skin. Fine lines around the eyes and mouth are
smoothed. Deep creases and frown lines are softened and the appearance of acne
scars is improved. Once the skin's outer layer is removed, the new skin
beneath is softer and smoother with a more youthful appearance.
Tiffani Hamilton M.D. of the Atlanta Dermatology, Vein, and Research
Center commented, "The Palomar Q-YAG 5 laser system is an important addition
to our program. The skin resurfacing provided by this system has become an
integral part of our comprehensive program to rejuvenate skin by smoothing out
wrinkles and providing improved skin tone and texture to our clients."
About Palomar Medical Technologies Inc: Palomar is a leading researcher
and developer of light-based systems for hair removal and other cosmetic
treatments. Recently, Palomar and The Gillette Company (NYSE: G) entered into
an agreement to complete development and commercialize a patented home-use,
light-based hair removal device for women. New and exciting indications are
being tested to further advance the hair removal market and other cosmetic
applications. Palomar pioneered the optical hair removal field, when, in 1996,
it introduced the first high-powered laser hair removal system. Since then,
many of the major advances in light-based hair removal have been based on
Palomar technology. There are now millions of light-based hair removal
procedures performed around the world every year in physician offices,
clinics, spas and salons.
For more information on Palomar and its products, visit Palomar's website
at http://www.palmed.com. To continue receiving the most up-to-date information and
latest news on Palomar as it happens, sign up to receive automatic e-mail
alerts by going to the E-mail Alerts page in the Investor Relations' section
of the website.
With the exception of the historical information contained in this
release, the matters described herein contain forward-looking statements,
including but not limited to statements relating to new markets, development
and introduction of new products, and financial projections that involve risk
and uncertainties that may individually or mutually impact the matters herein,
and cause actual results, events and performance to differ materially from
such forward-looking statements. These risk factors include, but are not
limited to, results of future operations, technological difficulties in
developing or introducing new products, the results of future research, lack
of product demand and market acceptance for current and future products, the
effect of economic conditions, challenges in managing joint ventures and
research with third parties, the impact of competitive products and pricing,
governmental regulations with respect to medical devices, including whether
FDA clearance will be obtained for future products, the results of litigation,
difficulties in collecting royalties, potential infringement of third-party
intellectual property rights, and/or other factors, which are detailed from
time to time in the Company's SEC reports, including the report on Form 10-K
for the year ended December 31, 2002 and the Company's quarterly reports on
Form 10-Q. Readers are cautioned not to place undue reliance on these forward-
looking statements, which speak only as of the date hereof. The Company
undertakes no obligation to release publicly the result of any revisions to
these forward-looking statements that may be made to reflect events or
circumstances after the date hereof or to reflect the occurrence of
unanticipated events.
Contacts:
Paul S. Weiner
Chief Financial Officer
Palomar Medical Technologies Inc
781-993-2411
ir@palmed.com
SOURCE Palomar Medical Technologies Inc
 back to top
Related links:
http://www.palmed.com
Company News On-Call:
http://www.prnewswire.com/comp/107555.html
CONTACT:
Paul S. Weiner, Chief Financial Officer of
Palomar Medical Technologies Inc, +1-781-993-2411, ir@palmed.com
|
